Dtp (Diphtheria, Tetanus, Pertussis) Vaccine Suppliers & Bulk Manufacturers
Available Forms: Injectable suspension (IM injection), Combination formulations
Available Strengths: 0.5 mL
Reference Brands: Daptacel , Boostrix , Adacel(US)
Category:
Vaccines
DTP vaccine stimulates the immune system to produce protective antibodies against diphtheria, tetanus, and pertussis. It prevents these serious diseases, reducing illness, complications, and transmission. Benefits include lifelong immunity, public health protection, and a significant decrease in disease-related morbidity and mortality globally when administered as recommended.
DTP (Diphtheria, Tetanus, Pertussis) Vaccine is available in Injectable suspension (IM injection), Combination formulations
and strengths such as 0.5 mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, DTP (Diphtheria, Tetanus, Pertussis) Vaccine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
DTP (Diphtheria, Tetanus, Pertussis) Vaccine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
DTP (Diphtheria, Tetanus, Pertussis) vaccines are approved in both the US and EU, supported by dossiers demonstrating safety, efficacy, and quality in line with GMP standards. In the US, FDA-licensed vaccines such as Daptacel and Boostrix require rigorous clinical evaluation. In the EU, CE-marked vaccines like INFANRIX meet in vitro diagnostic and pharmaceutical regulations. These vaccines undergo validation, stability testing, and extensive audits, with comprehensive documentation including safety profiles, clinical trial data, and manufacturing details. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees secure access to effective vaccines for immunization programs worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing